When HCPs were asked whether they believe that patients with rare bleeding disorders (e.g. factor VII deficiency, congenital fibrinogen deficiency, and others) experience less access to care as compared to those with more common bleeding disorders (e.g. VWD, factor VIII or IX deficiency), half the respondents surveyed (50%, N = 35) did not feel that having a rare bleeding disorder diagnosis hindered access to care. The gene discussed is VWF; the disease is factor VII deficiency.